$BABA: $600M DOJ settlement over illegal drug sales


Sentiment: Negative
The Wall Street Journal reports Alibaba and a U.S. payment processor will pay $600M to settle DOJ allegations tied to enabling merchants to sell/import illegal pharmaceuticals and other restricted items into the U.S. Beyond the one-time payment, the bigger overhang is compliance and monitoring burden (and potential future enforcement), which can pressure cross-border commerce growth and payment partner relationships.
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned